COVID-19 vaccine makers tell Congress that supply will surge soon

By Michael Erman and Manojna Maddipatla NEW YORK (Reuters) - COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations. Executives from Pfizer Inc, Moderna Inc and Johnson & Johnson - speaking at a hearing at the U.S. House of Representatives - said they would be able to supply enough vaccine to fully inoculate 130 million people in the United States by the end of March. The drugmakers also reaffirmed their commitments to supply more than enough doses necessary to vaccinate all Americans b...